Half-life
~1–6 minutes (plasma); CNS effects longer via nasal route
Evidence Level
High Evidence
Mechanism of Action
Binds OXTR distributed throughout CNS and periphery. Modulates HPA axis stress response, amygdala activation, dopaminergic reward circuits, and autonomic nervous system tone.
Published Research Ranges & Study Context
Studies have administered: 24–40 IU intranasal; 0.2–0.4mg IM in research
Important Research Framing
These are ranges reported in published scientific studies. They are provided for educational context only and do not constitute dosing recommendations. Individual study parameters vary by design, population, and research objectives. This information is not medical advice.
Primary Research Findings
Multiple human RCTs in trust behavior, autism social behavior, PTSD, and sexual arousal. Significant research in pair bonding and prosocial behavior. Cardiac protection in animal models.
High Evidence
Multiple large human RCTs available
Side Effects Observed in Research
Generally very safe; water retention at high doses (antidiuretic properties); rare cardiovascular effects monitored
Available Configurations (SKU Reference)
OT2
Compounds Studied in Combination
These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.
Want a Complete Research Monograph?
Our AI can generate a 2,000+ word deep-dive on Oxytocin Acetate — including full clinical trial summaries, pharmacokinetics, and research frontiers.
Generate Deep Dive in Research Chat
Research Education Only: This compound profile is for educational purposes only. All information is sourced from published scientific literature. This is not medical advice. Not for human consumption. Consult qualified medical professionals for any health decisions. Regulatory status varies by jurisdiction.